Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma
Condition(s):Head and Neck Cancer; Cancer of the Head and NeckLast Updated:January 10, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Head and Neck Cancer; Cancer of the Head and NeckLast Updated:January 10, 2024Recruiting
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:February 20, 2024Active, not recruiting
Condition(s):Head and Neck Cancer; Oral Cavity Cancer; Oropharyngeal CancerLast Updated:February 23, 2016Completed
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:July 20, 2011Unknown status
Condition(s):Head and Neck CancersLast Updated:January 3, 2019Unknown status
Condition(s):Head and Neck CancerLast Updated:December 31, 2020Terminated
Condition(s):Head and Neck NeoplasmsLast Updated:October 10, 2023Active, not recruiting
Condition(s):Carcinoma, Squamous Cell of Head and NeckLast Updated:November 13, 2017Terminated
Condition(s):Locally Advanced Squamous Cell Carcinoma of the Head and Neck RegionLast Updated:November 17, 2017Completed
Condition(s):HNSCCLast Updated:September 6, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.